These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 12519875

  • 1. Effect of discontinuation of growth hormone treatment on risk factors for cardiovascular disease in adolescents born small for gestational age.
    van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):347-53. PubMed ID: 12519875
    [Abstract] [Full Text] [Related]

  • 2. Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome.
    Van Pareren YK, De Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Drop SL.
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5442-8. PubMed ID: 12466334
    [Abstract] [Full Text] [Related]

  • 3. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T, Mulder P, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls.
    van Dijk M, Bannink EM, van Pareren YK, Mulder PG, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Jan; 92(1):160-5. PubMed ID: 17062774
    [Abstract] [Full Text] [Related]

  • 5. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC, van Pareren Y, Sas T, Arends N.
    Horm Res; 2003 Jan; 60 Suppl 3():113-4. PubMed ID: 14671407
    [Abstract] [Full Text] [Related]

  • 6. Small for gestational age (SGA): endocrine and metabolic consequences and effects of growth hormone treatment.
    Hokken-Koelega AC, De Waal WJ, Sas TC, Van Pareren Y, Arends NJ.
    J Pediatr Endocrinol Metab; 2004 Mar; 17 Suppl 3():463-9. PubMed ID: 15134308
    [Abstract] [Full Text] [Related]

  • 7. Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA).
    Arends NJ, Boonstra VH, Duivenvoorden HJ, Hofman PL, Cutfield WS, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):44-50. PubMed ID: 15638869
    [Abstract] [Full Text] [Related]

  • 8. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. High-dose growth hormone (GH) treatment in non-GH-deficient children born small for gestational age induces growth responses related to pretreatment GH secretion and associated with a reversible decrease in insulin sensitivity.
    de Zegher F, Ong K, van Helvoirt M, Mohn A, Woods K, Dunger D.
    J Clin Endocrinol Metab; 2002 Jan; 87(1):148-51. PubMed ID: 11788639
    [Abstract] [Full Text] [Related]

  • 11. Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age.
    Sas T, Mulder P, Aanstoot HJ, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):243-51. PubMed ID: 11207640
    [Abstract] [Full Text] [Related]

  • 12. Puberty in growth hormone-treated children born small for gestational age (SGA).
    Boonstra V, van Pareren Y, Mulder P, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5753-8. PubMed ID: 14671164
    [Abstract] [Full Text] [Related]

  • 13. Serum dehydroepiandrosterone sulfate levels and pubarche in short children born small for gestational age before and during growth hormone treatment.
    Boonstra VH, Mulder PG, de Jong FH, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2004 Feb; 89(2):712-7. PubMed ID: 14764786
    [Abstract] [Full Text] [Related]

  • 14. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age.
    van Pareren YK, Duivenvoorden HJ, Slijper FS, Koot HM, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5295-302. PubMed ID: 15531473
    [Abstract] [Full Text] [Related]

  • 15. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
    Bannink EM, van Doorn J, Mulder PG, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
    [Abstract] [Full Text] [Related]

  • 16. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Aug; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 17. Independent effects of prematurity on metabolic and cardiovascular risk factors in short small-for-gestational-age children.
    Willemsen RH, de Kort SW, van der Kaay DC, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2008 Feb; 93(2):452-8. PubMed ID: 18029462
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial.
    Sas T, de Waal W, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3064-70. PubMed ID: 10487666
    [Abstract] [Full Text] [Related]

  • 19. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections.
    Sas T, de Muinck Keizer-Schrama S, Aanstoot HJ, Stijnen T, Drop S.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):741-7. PubMed ID: 10848879
    [Abstract] [Full Text] [Related]

  • 20. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
    van Dijk M, Mulder P, Houdijk M, Mulder J, Noordam K, Odink RJ, Rongen-Westerlaken C, Voorhoeve P, Waelkens J, Stokvis-Brantsma J, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.